Zynerba Pharmaceuticals (NASDAQ:ZYNE) Insider Buying and Selling Activity
Insider Ownership Percentage: 10.79%
Zynerba Pharmaceuticals (NASDAQ ZYNE) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 8/22/2018 | John P Butler | Director | Buy | 5,000 | $6.43 | $32,150.00 | 5,000 |  |
| 8/6/2018 | Armando Anido | Chairman | Buy | 15,000 | $5.96 | $89,400.00 | 352,512 | |
| 8/6/2018 | James E Fickenscher | CFO | Buy | 8,518 | $5.97 | $50,852.46 | 20,718 | |
| 8/6/2018 | Terri B Sebree | President | Buy | 3,800 | $5.79 | $22,002.00 | 182,546 | |
| 5/30/2018 | Michael Rapp | Major Shareholder | Buy | 5,885 | $10.45 | $61,498.25 | | |
| 5/2/2018 | Michael Rapp | Major Shareholder | Buy | 15,000 | $10.46 | $156,900.00 | | |
| 3/22/2018 | Michael Rapp | Major Shareholder | Buy | 10,000 | $9.28 | $92,800.00 | | |
| 1/2/2018 | Michael Rapp | Major Shareholder | Buy | 15,000 | $12.99 | $194,850.00 | | |
| 10/23/2017 | Michael Rapp | Major Shareholder | Buy | 25,745 | $9.94 | $255,905.30 | | |
| 10/19/2017 | Michael Rapp | Major Shareholder | Buy | 44,255 | $9.59 | $424,405.45 | | |
| 5/15/2017 | Armando Anido | Chairman | Buy | 5,000 | $19.70 | $98,500.00 | 336,012 | |
| 5/12/2017 | James E Fickenscher | CFO | Buy | 5,200 | $19.82 | $103,064.00 | 12,200 | |
| 12/29/2016 | Michael Rapp | Major Shareholder | Buy | 10,000 | $15.85 | $158,500.00 | 1,354,115 | |
| 12/7/2016 | James E Fickenscher | CFO | Buy | 7,000 | $14.08 | $98,560.00 | 3,000 | |
| 8/16/2016 | Suzanne M Hanlon | Insider | Sell | 3,000 | $10.53 | $31,590.00 | 39,893 | |
(Data available from 1/1/2013 forward)
